Results 121 to 130 of about 15,205 (209)

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial [PDF]

open access: hybrid, 2021
Ankeet S. Bhatt   +13 more
openalex   +1 more source

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV) [PDF]

open access: bronze, 2022
Mingyu Kong   +6 more
openalex   +1 more source

Comparison of the effect of Sacubitril /Valsartan with Losartan and Captopril in improving right ventricular function in patients with right heart failure, a randomized clinical controlled trial [PDF]

open access: yes
Background: There is evidence supporting the efficacy of Sacubitril /Valsartan for improving left heart failure, but few studies have examined its effects on right ventricular (RV) dysfunction.
Hajahmadi, Marjan   +3 more
core   +2 more sources

Angiotensin receptor-neprilysin inhibitors: a new paradigm in heart failure with reduced ejection fraction [PDF]

open access: yes, 2018
Despite significant advances in the last 30 years in reducing morbidity and mortality from heart failure with reduced ejection fraction (HFrEF) with pharmacological and device-based therapies, patients remain at a high risk of adverse cardiovascular ...
Docherty, Kieran F., McMurray, John J.V.
core   +1 more source

Inibitori della neprilisina nel trattamento dell'insufficienza cardiaca : basi farmacologiche ed evidenze cliniche per l'associazione Sacubitril+Valsartan [PDF]

open access: yes, 2016
Lo scompenso cardiaco è una sindrome multifattoriale nella quale un evento cronico come l'ipertensione, oppure un evento acuto come l'infarto , sono responsabili di alterazioni funzionali che impediscono al cuore di espellere sangue sufficiente da ...
PERONDI, MICHELE
core  

Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study

open access: yesLipids in Health and Disease
Background and objective Dyslipidemia is significantly more common in those with concurrent chronic kidney disease (CKD) and chronic heart failure (CHF).
Manzhi Li   +6 more
doaj   +1 more source

Induction of ischaemic cardiomyopathy in mice without off‐target effects

open access: yes
Experimental Physiology, EarlyView.
Mark T. Waddingham, James T. Pearson
wiley   +1 more source

Sacubitril valsartan in aged patients with heart failure and reduced ejection fraction: a safe and beneficial therapy [PDF]

open access: bronze, 2022
José María Romero Otero   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy